Goodwin Procter LLP advised Moderna, Inc. (Nasdaq: MRNA) on its underwritten public offering of 26,315,790 shares of common stock at a public offering price of $19.00…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now